Facebook Twitter Instagram You Tube Pinterest LinkedIn RSS Podcasts Video Library Blog
 - Northwestern Memorial Hospital - Chicago

Ravi Kalhan, MD

Pulmonology, Critical Care Medicine

This physician accepts new patients.Read important legal notice

You may also call Northwestern Memorial's Physician Referral Department at 1.877.926.4NMH(4664) to arrange a new patient appointment.
Office Phone: 312-695-1800
Office Hours:
  • Monday:8:00 a.m. - 6:00 p.m.
  • Tuesday:12:00 p.m. - 6:00 p.m.
  • Friday:1:00 p.m. - 4:00 p.m.

Clinical Interests

Emphysema (COPD), Asthma, Alpha - 1 Antitrypsin Deficiency, Obstructive Airway Disease, Bronchitis, COPD

Education and Training

Medical Education:

Case Western Reserve University School of Medicine 2000

Residency:

Hospital of the University of Pennsylvania 2003

Fellowship:

Northwestern Mcgaw / Northwestern Memorial Hospital 2006

Board Certification

Critical Care Medicine, Pulmonary Disease

Locations and Directions

675 N. St. Clair
Galter 18-250
Chicago, IL 60611 312-695-1800

Biography

Ravi Kalhan, MD, MS is an Assistant Professor of Medicine at Northwestern University Feinberg School of Medicine and Director of the Northwestern Asthma and Chronic Obstructive Pulmonary Disease (COPD) Program where comprehensive care is provided to patients with asthma and COPD at all stages of severity. Dr. Kalhan additionally serves as director of the Alpha-1-Antitrypsin Deficiency Clinical Resource Center at Northwestern.

Dr. Kalhan attended college at Brown University in Providence, RI where he majored in modern American history. He subsequently entered medical school at Case Western Reserve University School of Medicine and completed his internal medicine residency at the Hospital of the University of Pennsylvania. He then came to Chicago where he pursued his fellowship training in Pulmonary and Critical Care Medicine at Northwestern Memorial Hospital, and has been on the Northwestern faculty since 2006.

Dr. Kalhan's clinical interests are in the care of patients with both asthma and COPD as well as alpha-1-antitrypsin deficiency. His research interests relate to respiratory epidemiology, in particular identification of early risk factors that impact the vulnerability of certain cigarette smokers to develop COPD. He is also involved in clinical trials of new therapies for both asthma and COPD.

Disclosure

View the full disclosure of external professional relationships
top